| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 234.60B | 220.18B | 236.54B | 236.39B | 223.52B | 176.23B |
| Gross Profit | 8.97B | 9.29B | 25.63B | 4.06B | -47.88B | 3.35B |
| EBITDA | 32.40B | 32.92B | 30.50B | 25.05B | -28.47B | 26.38B |
| Net Income | 5.83B | 6.23B | 4.32B | 2.39B | -45.46B | 1.96B |
Balance Sheet | ||||||
| Total Assets | 504.13B | 522.48B | 502.18B | 500.24B | 481.80B | 447.70B |
| Cash, Cash Equivalents and Short-Term Investments | 20.66B | 19.81B | 18.75B | 22.16B | 19.06B | 21.87B |
| Total Debt | 320.86B | 320.46B | 312.22B | 314.47B | 304.62B | 227.64B |
| Total Liabilities | 382.03B | 389.62B | 378.63B | 381.40B | 367.30B | 286.41B |
| Stockholders Equity | 119.91B | 130.40B | 121.36B | 116.80B | 112.61B | 159.48B |
Cash Flow | ||||||
| Free Cash Flow | -5.41B | -10.81B | -7.04B | -7.72B | -81.14B | -18.64B |
| Operating Cash Flow | 4.67B | 27.30B | 34.08B | 25.63B | -38.06B | 17.33B |
| Investing Cash Flow | -8.51B | -35.06B | -34.04B | -32.00B | -38.48B | -34.93B |
| Financing Cash Flow | 4.94B | 8.34B | -3.44B | 9.54B | 75.04B | 12.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
62 Neutral | ¥503.05B | -4.76 | 16.40% | 3.47% | -10.30% | -53.53% | |
57 Neutral | ¥180.87B | -9.52 | 17.23% | 2.31% | -7.70% | -16.43% | |
50 Neutral | ¥193.16B | -11.24 | 13.70% | 2.36% | -5.11% | -31.49% | |
49 Neutral | ¥50.35B | -2.83 | 4.73% | 2.31% | -6.92% | 44.23% | |
49 Neutral | ¥319.52B | -53.90 | 12.27% | 3.23% | -5.68% | -30.36% | |
43 Neutral | ¥894.82B | 1.23 | -22.13% | ― | -7.07% | -381.65% |